The University of Southampton
University of Southampton Institutional Repository

COVID-19 infection in primary central nervous system lymphoma treatment: Who is most at risk?

COVID-19 infection in primary central nervous system lymphoma treatment: Who is most at risk?
COVID-19 infection in primary central nervous system lymphoma treatment: Who is most at risk?
In their paper, Ferreri et al.1 from the International PCNSL Collaborative Group report on the clinical outcomes of patients with primary central nervous system lymphoma (PCNSL) and SARS-CoV-2 infection.2 This retrospective observational study comprises an impressive cohort of 91 patients given the rarity of this lymphoma subtype. In this study, 70% were infected with SARS-CoV-2 close to or during first-line treatment, 23% in follow up and 7% during salvage therapy. Among them, 16 participants were vaccinated, with the majority (88%) also infected during first-line treatment.
0007-1048
480-481
Lim, Sean
1afe5aa1-61a4-4a7b-927f-5e671f885196
Lim, Sean
1afe5aa1-61a4-4a7b-927f-5e671f885196

Lim, Sean (2022) COVID-19 infection in primary central nervous system lymphoma treatment: Who is most at risk? British Journal of Haematology, 199 (4), 480-481. (doi:10.1111/bjh.18416).

Record type: Letter

Abstract

In their paper, Ferreri et al.1 from the International PCNSL Collaborative Group report on the clinical outcomes of patients with primary central nervous system lymphoma (PCNSL) and SARS-CoV-2 infection.2 This retrospective observational study comprises an impressive cohort of 91 patients given the rarity of this lymphoma subtype. In this study, 70% were infected with SARS-CoV-2 close to or during first-line treatment, 23% in follow up and 7% during salvage therapy. Among them, 16 participants were vaccinated, with the majority (88%) also infected during first-line treatment.

Text
Br J Haematol - 2022 - Lim - COVID‐19 infection in primary central nervous system lymphoma treatment Who is most at risk - Version of Record
Download (645kB)

More information

e-pub ahead of print date: 26 August 2022
Published date: November 2022

Identifiers

Local EPrints ID: 470073
URI: http://eprints.soton.ac.uk/id/eprint/470073
ISSN: 0007-1048
PURE UUID: 44f44874-0b46-445c-8b87-635167bec68d
ORCID for Sean Lim: ORCID iD orcid.org/0000-0002-2768-4858

Catalogue record

Date deposited: 03 Oct 2022 16:34
Last modified: 12 Dec 2024 02:42

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×